Cargando…

Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus

BACKGROUND: The purpose of this study is to review the results of radiation therapy (RT) for hepatocellular carcinoma (HCC) with portal venous tumor thrombus (PVTT) in a Western patient population. METHODS: Thirty-four patients with HCC PVTT treated from 2007 to 2014 with RT were identified. Biologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holliday, Emma B., Tao, Randa, Brownlee, Zachary, Das, Prajnan, Krishnan, Sunil, Taniguchi, Cullen, Minsky, Bruce D., Herman, Joseph M., Kaseb, Ahmed, Raghav, Kanwal, Conrad, Claudius, Vauthey, Jean-Nicholas, Aloia, Thomas A., Chun, Yun Shin, Crane, Christopher H., Koay, Eugene J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833919/ https://www.ncbi.nlm.nih.gov/pubmed/29594206 http://dx.doi.org/10.1016/j.ctro.2017.04.003

Ejemplares similares

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy
por: De, Brian, et al.
Publicado: (2021)

Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies
por: Moningi, Shalini, et al.
Publicado: (2019)

Hyperfractionated abdominal reirradiation for gastrointestinal malignancies
por: Hunt, Andrew, et al.
Publicado: (2018)

Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases
por: De, Brian, et al.
Publicado: (2023)

Assessment of setup uncertainty in hypofractionated liver radiation therapy with a breath-hold technique using automatic image registration–based image guidance
por: Choi, Gye Won, et al.
Publicado: (2019)

Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation
por: Jensen, Garrett, et al.
Publicado: (2018)

IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer
por: Moningi, Shalini, et al.
Publicado: (2019)

Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma
por: Manzar, Gohar Shahwar, et al.
Publicado: (2022)

Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis
por: Corrigan, Kelsey L., et al.
Publicado: (2022)

Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer
por: Moningi, Shalini, et al.
Publicado: (2022)

Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma
por: De, Brian, et al.
Publicado: (2021)

Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution
por: Holliday, Emma B, et al.
Publicado: (2022)

Dose escalation for locally advanced pancreatic cancer: How high can we go?
por: Colbert, Lauren E., et al.
Publicado: (2018)

Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular Carcinoma
por: Kaseb, Ahmed O., et al.
Publicado: (2014)

Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiation Therapy in Patients with Pancreatic Cancer
por: Cazacu, Irina M., et al.
Publicado: (2023)

Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis
por: Dodoo, Grace N, et al.
Publicado: (2023)

Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic Cancer
por: Wang, Charles X., et al.
Publicado: (2022)

Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era
por: Abi Jaoude, Joseph, et al.
Publicado: (2021)

Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC
por: Colbert, Lauren E., et al.
Publicado: (2017)

Inflammation and pro-resolution inflammation after hepatobiliary surgery
por: Cata, Juan P., et al.
Publicado: (2017)

CEA as a blood-based biomarker in anal cancer
por: Hester, Robert, et al.
Publicado: (2021)

Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer
por: Moningi, Shalini, et al.
Publicado: (2020)

Imaging‐based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy
por: Amer, Ahmed M., et al.
Publicado: (2018)

Anal cancer treatment regimen considerations for the COVID-19 era: In regard to Tchelebi et al
por: Noticewala, Sonal S., et al.
Publicado: (2020)

Hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus
por: Kamiyama, Toshiya, et al.
Publicado: (2017)

Portal vein tumor thrombus from gastric cancer
por: Liang Ong, Sidney Ching, et al.
Publicado: (2018)

NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience
por: Bagley, Alexander F., et al.
Publicado: (2022)

Middle bile duct cancer with portal vein tumor thrombus
por: Shimoda, Mitsugi, et al.
Publicado: (2008)

Transileocolic Vein Obliteration for Bleeding Rectal Varices with Portal Thrombus
por: Arai, Hirotaka, et al.
Publicado: (2013)

Spontaneous Regression of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
por: Koya, Yudai, et al.
Publicado: (2018)

Portal Vein Tumor Thrombus: No Longer a Death Sentence
por: Esposito, Phillip, et al.
Publicado: (2021)

The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
por: Luo, Fangzhou, et al.
Publicado: (2021)

KRAS mutation in colorectal cancer metastases after adjuvant FOLFOX for the primary
por: Vauthey, J-N, et al.
Publicado: (2012)

Robotic total gastrectomy with thrombectomy and portal vein reconstruction for gastric cancer and portal vein tumor thrombus
por: Yamamoto, Masaaki, et al.
Publicado: (2022)

Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus
por: Katagiri, Satoshi, et al.
Publicado: (2013)

The role of radiotherapy in the treatment of hepatocellular carcinoma with portal vein tumor thrombus
por: Yeh, Shyh-An, et al.
Publicado: (2015)

EUS-guided FNA of a portal vein thrombus in hepatocellular carcinoma
por: Kayar, Yusuf, et al.
Publicado: (2015)

Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma
por: Sun, Ju-Xian, et al.
Publicado: (2016)

Gallbladder cancer with tumor thrombus in the portal vein: A case report
por: Zhang, Xiao-Zhen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gdfd70kqa79k96qc39pc75nbgf